IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOPark Medi World

About Park Medi World

Incorporated in 2011, Park Medi World Limited is a chain of private hospitals with the majority of its operations in North India, having a total bed capacity of 3,000 beds as of September 30, 2024.The firm has 13 multi-super speciality hospitals in its 'Park' brand. All the hospitals have NABH accreditation by the National Accreditation Board for Hospitals & Healthcare Providers, and seven are also NABL-accredited by the National Accreditation Board for Testing and Calibration Laboratories. Facilities are present in Haryana, Delhi, Punjab, and Rajasthan.The Park Hospital provides over 30 super specialty and specialty services like internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.The hospitals have 805 intensive care unit (ICU) beds, 63 operating theatres (OTs), and an oxygen generation plant in each of them to cater to critical care.

Checklist Quality Analysis

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Park Medi World

Park Medi World

Open Date

10 Dec 2025

Close Date

12 Dec 2025

listed

Min Investment

₹14904

Lot Size

92 Shares

Issue Size

₹920 Cr

Price Range

₹154 - ₹162

Listing Date

Dec 17, 2025

IPO Doc

RHP PDF

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹4.5(+2.00%)GMP
2.78%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Park Medi World IPO - Issue Objectives

The company will use ₹ 60.5 crore to develop a new hospital under subsidiary Park Medicity (NCR). The company will use ₹ 27.46 crore for purchase of medical equipment by itself and its subsidiaries. The company will use ₹380 crore towards pre-payment in full or part of certain borrowings Part of the IPO proceeds will be used for general corporate purposes and unidentified acquisitions.

Development of new hospitals

7.8%

Purchase of medical equipment

3.5%

Repayment of borrowings

49.3%

General corporate purposes

39.2%

1

Development of new hospitals

The company will use ₹ 60.5 crore to develop a new hospital under subsidiary Park Medicity (NCR).

7.80%
2

Purchase of medical equipment

The company will use ₹ 27.46 crore for purchase of medical equipment by itself and its subsidiaries.

3.50%
3

Repayment of borrowings

The company will use ₹380 crore towards pre-payment in full or part of certain borrowings

49.30%
4

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and unidentified acquisitions.

39.20%

IPO Subscription Status

QIB
12.07x
NII
15.93x
Individual
3.32x
Total
8.52x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Park Medi World

In Cr.

Key Performance Indicator30-Sep-25 (In Cr.)31-Mar-25 (In Cr.)31-Mar-24 (In Cr.)31-Mar-23 (In Cr.)
Revenue823.391425.971263.081272.18
EBITDA217.14372.17310.30390.34
Expenses
Profit After Tax139.14213.22152.01228.19
Assets2320.932133.701912.101592.82
Net Worth1153.051021.86815.98667.55
Reserves1187.771049.40858.63653.09
Borrowing733.91682.07686.71575.68

Park Medi World - Promoter(s)

Dr. Ajit Gupta

Dr. Ankit Gupta

Pre Issue Share Holding

95.55%

Post Issue Share Holding

82.89%

About Strength & Risks

Why this IPO looks interesting

Key positives investors may want to consider before applying.

01

Market leadership in North India

The company is the second-largest private hospital chain in North India, with 3,250 beds as of September 30, 2025, including 870 ICU beds and 67 OTs, and the largest in Haryana with 1,600 beds. Its 14 NABH-accredited hospitals are strategically located across Delhi, Haryana, Punjab, and Rajasthan, benefiting from a cluster-based expansion model that enhances brand recall and operational synergies.

02

High-quality, affordable care

The company addresses the mass-market demand for healthcare, which is driven by middle-class patients, ensuring affordability with the usage of advanced technologies such as robotic iMARS surgical systems. Strong speciality mix with 30+ super-specialities limits concentration risk; Internal Medicine comprised 29.65% of revenue, Neurology 14.98%, and Urology 10.85%, as of H1FY26.

03

Demonstrated acquisition and integration

With 8 successful acquisitions, including Grecian Mohali and Healing Touch Ambala, Park Medi World has added 1,650 beds. The acquisitions contributed 55.12% of revenue and 61.90% to PAT in H1FY26 with strong turnaround capabilities, demonstrating scalable SOP-driven integration. Further, it is also expanding its presence into Uttar Pradesh through the Kanpur hospital acquisition.

What investors should watch closely

Risk factors and possible pressure points around the offer.

01

High contingent liabilities

As of September 30, 2025, contingent liabilities (excluding guarantees) stood at 11.66% of net worth, while corporate guarantees constituted 71.58% of net worth. If tax demands of ₹10.46 crore or GST claims of more than ₹111.90 crore and ₹12.14 crore materialise adversely, cash flows and financial stability could be affected.

02

Recent revenue decline and margin pressure

Revenue declined 1.88% YoY in FY24, while cost of materials consumed/services rendered jumped 26.91%, resulting in a 33.39% decline in PAT. The company’s profitability is sensitive to patient volumes, cost inflation, and operational disruptions such as floods or renovation delays.

Contact Details

Park Medi World

12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, New Delhi 110018, Delhi New Delhi, New Delhi, 110018

+91124696000
company.secretary@parkhospital.in
http://www.parkhospital.in/

Registrar Contact Details

Kfin Technologies Ltd.

04067162222
parkmedi.ipo@kfintech.com
https://kosmic.kfintech.com/ipostatus/

Park Medi World IPO - FAQs

Park Medi World IPO is a Mainboard Listed IPO. The issue is priced at ₹154-162 per equity share. The minimum order quantity is 92 Shares. The IPO opens on 10 Dec, and closes on 12 Dec. Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

IPO Timeline

  • Pre Apply2025-12-08
  • Bidding Starts2025-12-10
  • Bidding Ends2025-12-12
  • Allotment Finalisation2025-12-15
  • Release of Funds2025-12-16
  • Demat Transfer2025-12-16
  • Listing2025-12-17
04

Asset-ownership model

With 10 out of 14 hospitals owned, the company enjoys benefits from lower overheads and stronger control over quality and cash flows. Indeed, its gross block per bed of ₹0.34 crore was the lowest amongst peers in FY25 versus an industry average of ₹1.06 crore, thereby commanding superior capital efficiency and reinvestment capacity.

03

High attrition amongst medical professionals

As of September 30, 2025, the attrition for medical professionals, particularly doctors, stands at 33.72%, while that of resident medical officers stands at 52.02%. Talent retention will be key to the hospital network amidst fierce competition, and continued attrition could affect service quality and patient inflow.

04

Revenue concentration in Haryana

The revenue contribution of hospitals in Haryana accounted for 69.06% in H1FY26, 73.43% in FY25, and 76.92% in FY24. Any regional economic or political disruptions, regulatory changes, or operational setbacks could disproportionately impact performance.

05

High operational cost structure

The group continues to incur significant operational expenses on medical consumables, pharmacy items, and clinical staffing. Material cost, employee benefit expenses, and professional fees together accounted for 64.10% of total expenses in H1FY26 and 67.26% in FY25. There is limited pricing flexibility given the presence of government tariffs, regulatory caps, and competitive pressures. Any increase in operational cost that cannot be passed on to the patients will have an adverse impact on margin and overall profitability.